Dr Danielle Anderson

Position:: Medical Scientist
Theme(s):: Viral Infectious Diseases
Discipline(s):: Discovery Research
Unit(s):: The University of Melbourne, Department of Microbiology and Immunology (DMI) , The Royal Melbourne Hospital, Victorian Infectious Diseases Reference Laboratory (VIDRL)

Dr Danielle Anderson received her PhD from Curtin University of Technology in 2007, majoring in virology. At the Doherty Institute, she is a Medical Scientist at the Royal Melbourne Hospital's Victorian Infectious Diseases Reference Laboratory. Her research is directed toward determining and understanding viral pathogenesis, particularly high consequence pathogens. Dr Anderson focuses on novel and emerging viruses and the development of diagnostic platforms for the identification of clinically relevant emerging pathogens.

Key Achievements
Publications

Key Achievements
- Dr Danielle Anderson studies viral pathogenesis in animal models. In addition to molecular and virological laboratory expertise, she has extensive experience in designing high throughput studies and has trained and worked at BSL3 facilities in Singapore (Duke-NUS Medical School), Germany (Paul-Ehrlich-Institut) and the USA (Duke University), and a BSL4 facility in China (Wuhan Institute of Virology). Her laboratory in Singapore was the fourth worldwide to isolate SARS-CoV-2. She is a co-inventor of cPass, a surrogate neutralization assay commercialized by GenScript that allows the detection of SARS-CoV-2 antibodies without the need for BSL3 containment.
Publications

Loading ORCID data…